Phase 2 Readout
SLN: Phase 2 Readout: divesiran
September 30, 2026 · divesiran. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- September 30, 2026
- Company
- Silence Therapeutics Plc (SLN)
- Drug
- divesiran
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout~quarter
Phase 2 Readout: divesiran
- Drug
- divesiran
- Indication
- polycythemia vera (PV)